Starmer's Crisis and the Women's Health Culture War

Labour's vetting scandal puts Starmer's authority in question — while Britain's women's health debate fractures along gender identity lines.

Starmer's Crisis and the Women's Health Culture War
Photo by Philip Strong on Unsplash

Editorial digest April 17, 2026
Last updated : 08:19


Two crises, one week. Neither is accidental. Both say something uncomfortable about the state of Britain — about who gets to hold power, who gets to be believed, and who gets to speak for whom.

The Mandelson Affair: When "Vetting" Is Just a Word

Peter Mandelson is one of the most surveilled politicians in British history. The man has been sacked twice from Cabinet, appointed EU Trade Commissioner, ennobled, and handed the Washington ambassadorship — all by Labour governments who knew exactly who they were getting. So the idea that Keir Starmer's team somehow failed to vet him properly before a controversial appointment strains credulity almost beyond repair.

According to the Independent, a top civil servant has been sacked over the vetting scandal surrounding the Labour peer. Starmer is now facing calls from opposition parties to resign. The Prime Minister's office, characteristically, has chosen process as its shield — blaming procedure, blaming oversight, blaming anything but political judgement.

Here is the question no one in Westminster wants to answer: what exactly does "vetting failure" mean when the subject's biography is longer than most government white papers? Mandelson didn't become controversial last Tuesday. His appointment to any sensitive role was always a political bet, the kind where the downside risk was visible from orbit. Calling it a vetting failure is either deliberate naivety or a very convenient escape hatch.

Starmer built his brand on procedural seriousness — the careful lawyer, the rule-follower, the man who was not Boris Johnson. That brand is now doing heavy lifting it was never designed to bear. When your flagship virtue is competence, you cannot afford the scandals that competence is supposed to prevent.

The opposition parties are calling for his head. They may not get it. But they don't need to. The damage is subtler and more durable: every future claim to managerial rigour lands 10 percent lighter.

The Body You Live In: Who Gets to Speak for Women's Health?

Somewhere between the political theatre, a quieter but no less revealing story is playing out in the world of women's health advocacy.

Steph Richards, a trans woman who had been involved in endometriosis charity work, has left that role — after the work attracted criticism from former Home Secretary Suella Braverman, according to the BBC. Separately, podcaster Alexandra Morris has been drawing attention to how women describing endometriosis symptoms are routinely dismissed by doctors.

These two stories are not the same story. But they have collided in the same news cycle for a reason.

Endometriosis affects roughly one in ten women. The average time to diagnosis in the UK is still around eight years — eight years of pain, misdiagnosis, and being told it's probably just period cramps. This is not an abstract policy failure. It is a lived reality for millions of people, and Morris's advocacy work draws on that reality.

The question of trans inclusion in women's health spaces is genuinely contested. Reasonable people disagree — including within feminist movements, within medicine, and within the charities themselves. What is not reasonable is using those disagreements as a political weapon while the underlying health crisis goes unaddressed. Braverman's intervention lands in a landscape where women are already fighting to be taken seriously by a medical establishment that has historically under-researched, under-diagnosed, and under-funded conditions that affect them disproportionately.

The charitable sector is left to absorb the political fallout of a culture war it did not declare. And the people who suffer most from that fallout are, predictably, the patients — whose diagnosis will be delayed regardless of who wins the argument about who gets to advocate for them.

At first glance, a Labour vetting scandal and a row over trans inclusion in health charities have nothing in common. Look again.

Both are stories about legitimacy — about who gets to occupy a role, who gets to be trusted, and what happens when the institutions that are supposed to adjudicate those questions look compromised or captured.

Starmer's problem is that his authority rests on a claim to institutional credibility that his own government keeps undermining. The women's health debate is partly a fight about the same thing: whose experience of an institution — in this case, medicine — counts as authoritative.

Britain is not short of opinion on these questions. It is short of institutions that command enough trust to answer them.

That is the real story of this week. Not the specific scandal, not the specific resignation. The steady, structural erosion of confidence in the bodies — political, medical, charitable — that are supposed to know what they're doing.

What to watch: Whether the civil servant's sacking satisfies Parliament or becomes the first domino in a longer accountability chain. And whether the endometriosis advocacy community finds a way to keep the health argument front and centre, rather than letting it be buried under the culture war.